Nisa Leung

Courtesy of Qiming Venture Partners
  • Title
    Managing Partner
  • Company/Affiliation
    Qiming Venture Partners
  • Country/Territory
    Hong Kong

China is the world's second-largest health care market‚ and Nisa Leung is ready to meet its demand. The lion's share of funding at Qiming, whose health care practice she launched in 2006, is directed toward health care bets: Leung oversees some 220 startups which collectively hold 300 drug assets. The Stanford MBA grad's portfolio of successes includes insulin provider Gan & Lee Pharmaceuticals and COVID-19 vaccine maker CanSino Biologics.